Literature DB >> 19486785

Serum chlamydial lipopolysaccharide as a prognostic factor for a new cardiovascular event.

Erkki Pesonen1, Terttu Tiirola, Eeva Andsberg, Matti Jauhiainen, Matti Paldanius, Kenneth Persson, Pekka Saikku, Seppo Sarna, Hans Ohlin, Maija Leinonen.   

Abstract

BACKGROUND: Infections caused by Chlamydia pneumoniae are considered to participate in inflammatory processes leading to coronary artery disease. After a primary infection, the bacteria remain dormant intracellularly causing a chronic inflammatory stimulus.
MATERIALS AND METHODS: Blood samples were obtained from 235 patients with acute myocardial infarction (AMI) and 108 patients with unstable angina pectoris (UA). We evaluated the prognostic significance of bacterial and viral antibody titers, serum troponin T, C-reactive protein, and chlamydial lipopolysaccharide (cLPS) concentrations during acute coronary syndrome of patients with AMI and UA for cardiovascular death and new UA and AMI that required hospital care during a 6-year follow-up.
RESULTS: Serum cLPS levels correlated with C-reactive protein and serum troponin T concentrations during acute coronary events. Patients with AMI had significantly higher serum concentration of cLPS compared with patients with UA. Enterovirus antibody titers and cholesterol-lowering therapy at admission of the index event were negatively correlated with cLPS concentration (r = -.198, P = .0003 and r = -.26, P = .019, respectively). The presence of circulating cLPS was associated with a hazard ratio of 2.04 for a new cardiovascular event during the follow-up period (P = .006). The area under the curve in the receiver operating graph was .572.
CONCLUSION: cLPS is evidently liberated from the infected atherosclerotic tissue during an acute coronary event. Our study supports the view that inflammation caused by C. pneumoniae infection is an important but as yet poorly understood factor in the development of atherosclerosis and may play a role in acute vascular events.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19486785     DOI: 10.1016/j.hrtlng.2008.06.001

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  3 in total

1.  Preparation and evaluation of monoclonal antibodies against chlamydial protease-like activity factor to detect Chlamydia pneumoniae antigen in early pediatric pneumonia.

Authors:  J Zheng; T Ding; Z Chen; H Fang; H Li; H Lu; Y Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-12       Impact factor: 3.267

Review 2.  Laboratory diagnosis of persistent human chlamydial infection.

Authors:  Mirja Puolakkainen
Journal:  Front Cell Infect Microbiol       Date:  2013-12-17       Impact factor: 5.293

3.  Chlamydia pneumoniae infection and cardiac risk factors in patients with myocardial infection.

Authors:  Zohreh Azarkar; Majid Jafarnejad; Mahmood Zaedast; Alireza Saadatjou; Parvaneh Portoghali
Journal:  ARYA Atheroscler       Date:  2011
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.